Medical specialists from India tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung

Total 24 results

Akhil Kapoor
Seen in:
- Uttar Pradesh, Varanasi, Tata Memorial Centre - Homi Bhabha Cancer Hospital
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Amit Joshi
Seen in:
- Maharashtra, Mumbai, Tata Memorial Hospital
Trials:
- NCT04819100 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Anoop Thattungal Manoharan
Seen in:
- Kerala, Thiruvananthapuram, Regional Cancer Centre - Thiruvananthapuram
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Arun Sankar
Seen in:
- Kerala, Thiruvananthapuram, Regional Cancer Centre
- Kerala, Thiruvananthapuram, Regional Cancer Centre - Thiruvananthapuram
Trials:
- NCT04819100 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
Bivas Biswas
Seen in:
- West Bengal, Kolkata, Tata Medical Center
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Dr. Anil Tibdewal, MD
Seen in:
- Maharashtra, Mumbai, Tata Memorial Hospital
- Maharashtra, Mumbai, Tata Memorial Hospital, Parel
Trials:
- NCT05278052 (Principal Investigator)
- NCT05277844 (Principal Investigator)
- NCT05236946 (Principal Investigator)
Conditions:
Gaurav Prakash
Seen in:
- Chandigarh, Postgraduate Institute of Medical Education & Research
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Kartar Singh
Seen in:
- Maharashtra, Nagpur, Rashtrasant Tukdoji Regional Cancer Hospital
- Maharashtra, Nagpur, Rashtrasant Tukdoji Regional Cancer Hospital and Research Centre (RSTRCH)
Trials:
- NCT04819100 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
lokesh k n
Seen in:
- Karnataka, Bengaluru, SRV Hospitals
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Mansi Sharma
Seen in:
- Delhi, New Delhi, Rajiv Gandhi Cancer Institute And Research Centre
Trials:
- NCT04819100 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Minish mahendra Jain
Seen in:
- Maharashtra, Pune, Grant Medical Foundation - Ruby Hall Clinic
- Maharashtra, Pune, Ruby Hall Clinic and Grant Medical Foundation
Trials:
- NCT04211337 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
Nilesh Dhamne
Seen in:
- Maharashtra, Kolhāpur, Kolhapur Cancer Centre Private Limited
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Prabagar Manickam
Seen in:
- Tamil Nadu, Coimbatore, Ashwin Hospital
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Prakash Pandit
Seen in:
- Maharashtra, Nashik, HCG Manavata Cancer Centre
Trials:
- NCT03390686 (Principal Investigator)
Conditions:
- Lung Cancer;
- Non-small Cell Lung Cancer
Prasanth Ganesan
Seen in:
- Puducherry, Jawaharlal Institute Of Postgraduate Medical Education And Research
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Rajnish Nagarkar
Seen in:
- Maharashtra, Nashik, HCG Manavata Cancer Centre
Trials:
- NCT04819100 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
Rajnish Vasant Nagarkar
Seen in:
- Maharashtra, Nashik, HCG Manavata Cancer Centre
Trials:
- NCT04975308 (Principal Investigator)
- NCT04211337 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
Rashmi A. Gudur
Seen in:
- Maharashtra, Karad, Krishna Institute of Medical Sciences - Karad
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Rohan Bhise
Seen in:
- Karnataka, Belagave, KLES Dr. Prabhakar Kore Hospital & M.R.C
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Sadashivudu Gundeti
Seen in:
- Telangana, Hyderabad, Nizam's Institute of Medical Sciences
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Sourav Mishra
Seen in:
- Odisha, Bhubaneswar, All India Institute of Medical Sciences
Trials:
- NCT05514054 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
Sunil Choudhari
Seen in:
- Uttar Pradesh, Varanasi, Banaras Hindu University
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Tushar Vishvasrao Patil
Seen in:
- Maharashtra, Pune, Sahyadri Super Speciality Hospital
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Ullas Batra
Seen in:
- Delhi, New Delhi, Rajiv Gandhi Cancer Institute And Research Centre
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis

Clinical Trials on Carcinoma, Non-Small-Cell Lung

Sidney Kimmel Cancer Center at Thomas Jefferson...
Bristol-Myers Squibb

Completed

Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...

United States
National Cancer Institute (NCI)

Completed

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Stage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Lung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7

United States, Puerto Rico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...

United States
National Cancer Institute (NCI)

Terminated

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
M.D. Anderson Cancer Center

Active, not recruiting

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...

United States
University of Southern California
National Cancer Institute (NCI); Society of Thoracic Radiology

Active, not recruiting

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...

United States
National Cancer Institute (NCI)

Completed

EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States

Medical specialists from India tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung

Clinical Trials on Carcinoma, Non-Small-Cell Lung

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations